| |
|
|
|
Oxford Global, Boston, USA
21-22 October 2014
R&D Models For The Future
Open innovation: new initiatives and industry case studies
Reviving existing drug products: increasing therapeutic potential
Expanding therapeutic areas: pain, anti-addiction, orphan diseases
Tools for measuring the success of research partnerships
Practical innovation: what can we learn from biotechs?
Accessing external innovation: how, where and who Screening & Assays: Enabling Technologies
Phenotypic screening vs target-based screening
High content analysis: live cell imaging, 3D cell based assays, flow cytometry
Developing disease relevant assays
New technologies for gene expression profiling
iPSC and primary cells: physiologically relevant assays
Technology platform case studies: NMR & SPR Discovery Chemistry & Drug Design
Fragment based and structure based drug discovery
Analysing structure-activity relationships
Advances in computational chemistry & knowledge-based design
De-risking through design: achieving selectivity and specificity
Increasing molecular complexity: considering solubility, drugability and potency
Medicinal chemistry case studies
Supporting Innovation: Translational Approaches & Informatics Tools
Making the most of discovery data: compound optimisation and safety assessment
Utilising predictive technologies
New data analysis and integration platforms
Legacy data and collaborative strategies: tackling informatics challenges
DMPK and ADMET: building an integrated pipeline
|
|
|
|
|
|
|
|
Organized by:
|
|
Oxford Global Conferences |
|
|
Invited Speakers:
|
|
- Sarah Blendermann
Senior Director, Chemistry & Pharmacology, Business Technology, Pfizer - Kevin Burgess
Rachal Professor of Chemistry, Texas A&M University - Michael Clark
Associate Director of Chemistry, Vertex Pharmaceuticals, Inc - Chris De Savi
Associate Director, Medicinal Chemistry Cancer Research, AstraZeneca - Mohanraj Dhanabal
Senior Principal Investigator, Discovery Technologies, Molecular Pharmacology, EMD Serono - Michael Finley
Associate Director, Small Molecule Screening, Merck - Nahor Haddish-Berhane
Senior Principal Scientist, Pfizer - Christopher Hale
Scientist, Discovery Technologies, Amgen - David Hayes
Director of Enzymology, Discovery Sciences, AstraZeneca - Jörg Holenz
Director, Discovery and Preclinical Sciences, Neuroscience Innovative Medicines, AstraZeneca Neurosciences - Wei-Sheng Huang
Director of Discovery Chemistry, ARIAD Pharmaceuticals - Mark Hurle
Senior Scientific Investigator, Computational Biology, GSK - Jetze J. Tepe
Associate Professor, Chemistry Department, Michigan State University - Lyn Jones
Head Rare Diseases Chemistry, Head Chemical Biology, Pfizer - Roland Kolbeck
Senior Director, RIA Research, Medimmune - Lisa Mendoza
Associate Director, Global External Innovation & Alliances, Bayer HealthCare - Debra Peattie
Life Science Director & Entrepreneur-in-Residence, GSK - Tom Plasterer
Principal Informatics Scientist-Knowledge Engineering & Information Science, AstraZeneca - Brian A. Pollok
Entrepreneur-In-Residence, University of Virginia - Deepak Rajpal
Director, Computational Biology, GSK - Thomas Schroeter
Senior Principal Scientist, Compound Safety Prediction-In Vitro Models Group, Pfizer - Paul Scola
Group Leader, BMS - David Sedlock
Senior Director, R&D Systems, Millennium Pharmaceuticals, The TAKEDA Oncology Company - Morten Sogaard
Executive Director and Head Biotechnology and Precision Medicine External R&D Innovation, Pfizer - Suvit Thaisrivongs
Vice President, Pfizer - Patrick Trojer
Senior Director, Constellation Pharmaceuticals - Chris Waller
Director Cheminformatics, Merck - Craig Wegner
Executive Director, Translational Science, Emerging Innovations Unit, Scientific Partnering & Alliances, AstraZeneca - Wendy Young
Director, Medicinal Chemistry, Genentech
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
N/A
|
|
|
|
|
|
|
|
Registration:
|
|
To register your interest and to find out more information on available discounts, please contact Danielle Dalby on d.dalby@oxfordglobal.co.uk or call +44 (0)1865 248455.
|
|
|
E-mail:
|
|
d.dalby@oxfordglobal.co.uk
|
|
|
|
|
|
|
|
|